Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway

International Journal of Oncology

Volumn 48, Issue 6, 2016, Pages 2415-2424

  Koguchi, Tomoyuki ^a,b   Tanikawa, Chizu ^a   Mori, Jinichi ^a   Kojima, Yoshiyuki ^b   Matsuda, Koichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Inositol 3 phosphate synthase; Myo inositol; P53

Indexed keywords

DOXORUBICIN; INOSITOL; INOSITOL 3 PHOSPHATE SYNTHASE; PROTEIN P53; SYNTHETASE; UNCLASSIFIED DRUG; MESSENGER RNA; MYOINOSITOL 1 PHOSPHATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; BIOSYNTHESIS; BLADDER CANCER; BREAST CANCER; CELL CYCLE ARREST; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; ENERGY METABOLISM; EXON; GENE EXPRESSION REGULATION; GLYCOLYSIS; HCT116 CELL LINE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; ISYNA1 GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; SENESCENCE; SQUAMOUS CELL LUNG CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; DNA MICROARRAY; GENETICS; HCT 116 CELL LINE; HEK293 CELL LINE; HEP-G2 CELL LINE; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; HCT116 CELLS; HEK293 CELLS; HEP G2 CELLS; HUMANS; INOSITOL; MICE; MICE, KNOCKOUT; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84964688912     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3456     Document Type: Article

References (41)

1. Brady CA and Attardi LD: p53 at a glance. J Cell Sci 123: 2527-2532, 2010.
2. Levine AJ and Oren M: The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9: 749-758, 2009.
3. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ and Mak TW: DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824-1827, 2000.
4. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E and Vousden KH: TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120, 2006.
5. Hu W, Zhang C, Wu R, Sun Y, Levine A and Feng Z: Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA 107: 7455-7460, 2010.
6. Kenzelmann Broz D, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A and Attardi LD: Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 27: 1016-1031, 2013.
7. Ju S, Shaltiel G, Shamir A, Agam G and Greenberg ML: Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast. J Biol Chem 279: 21759-21765, 2004.
8. Croze ML and Soulage CO: Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95: 1811-1827, 2013.
9. Maeba R, Hara H, Ishikawa H, Hayashi S, Yoshimura N, Kusano J, Takeoka Y, Yasuda D, Okazaki T, Kinoshita M, et al: Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. J Nutr Sci Vitaminol (Tokyo) 54: 196-202, 2008.
10. Mukai T, Kishi T, Matsuda Y and Iwata N: A meta-analysis of inositol for depression and anxiety disorders. Hum Psychopharmacol 29: 55-63, 2014.
11. Lam S, McWilliams A, LeRiche J, MacAulay C, Wattenberg L and Szabo E: A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol Biomarkers Prev 15: 1526-1531, 2006.
12. Han W, Gills JJ, Memmott RM, Lam S and Dennis PA: The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev Res (Phila) 2: 370-376, 2009.
13. Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, Cooper K, Walker D, McWilliams A, Liu G, et al: Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med 2: 26ra25, 2010.
14. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, et al: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862, 2000.
15. Tanikawa C, Matsuda K, Fukuda S, Nakamura Y and Arakawa H: p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 5: 216-223, 2003.
16. Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T, Tokunaga T, Takeda N, Suda Y, Abe S, et al: Enhanced prolif-erative potential in culture of cells from p53-deficient mice. Oncogene 8: 3313-3322, 1993.
17. Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K, Komune T, Sato T, Saya H, Li JD, et al: p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol Cell Biol 28: 6557-6567, 2008.
18. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1: 45-49, 1992.
19. Michell RH: Inositol derivatives: Evolution and functions. Nat Rev Mol Cell Biol 9: 151-161, 2008.
20. Seelan RS, Lakshmanan J, Casanova MF and Parthasarathy RN: Identifiication of myo-inositol-3-phosphate synthase isoforms: Characterization, expression, and putative role of a 16-kDa gamma(c) isoform. J Biol Chem 284: 9443-9457, 2009.
21. Konarzewska P, Esposito M and Shen CH: INO1 induction requires chromatin remodelers Ino80p and Snf2p but not the histone acetylases. Biochem Biophys Res Commun 418: 483-488, 2012.
22. Valluru R and van den. Ende W: Myo-inositol and beyond-emerging networks under stress. Plant Sci 181: 387-400, 2011.
23. Deranieh RM, He Q, Caruso JA and Greenberg ML: Phosphorylation regulates myo-inositol-3-phosphate synthase: A novel regulatory mechanism of inositol biosynthesis. J Biol Chem 288: 26822-26833, 2013.
24. Parthasarathy RN, Lakshmanan J, Thangavel M, Seelan RS, Stagner JI, Janckila AJ, Vadnal RE, Casanova MF and Parthasarathy LK: Rat brain myo-inositol 3-phosphate synthase is a phosphoprotein. Mol Cell Biochem 378: 83-89, 2013.
25. Henry SA, Gaspar ML and Jesch SA: The response to inositol: Regulation of glycerolipid metabolism and stress response signaling in yeast. Chem Phys Lipids 180: 23-43, 2014.
26. Guan G, Dai P and Shechter I: cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase. Arch Biochem Biophys 417: 251-259, 2003.
27. Chauvin TR and Griswold MD: Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium. Biol Reprod 70: 744-751, 2004.
28. Ye Y, Jin L, Wilmott JS, Hu WL, Yosufi B, Thorne RF, Liu T, Rizos H, Yan XG, Dong L, et al: PI(4, 5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nat Commun 4: 1508, 2013.
29. Ohnishi T, Murata T, Watanabe A, Hida A, Ohba H, Iwayama Y, Mishima K, Gondo Y and Yoshikawa T: Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis. J Biol Chem 289: 10785-10796, 2014.
30. Eagle H, Oyama VI, Levy M and Freeman AE: Myo-inositol as an essential growth factor for normal and malignant human cells in tissue culture. J Biol Chem 226: 191-205, 1957.
31. Hecht SS, Upadhyaya P, Wang M, Bliss RL, McIntee EJ and Kenney PM: Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myoinositol, individually and in combination. Carcinogenesis 23: 1455-1461, 2002.
32. Lee HJ, Lee SA and Choi H: Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis. Asian Pac J Cancer Prev 6: 41-47, 2005.
33. Nishino H: Phytochemicals in hepatocellular cancer prevention. Nutr Cancer 61: 789-791, 2009.
34. Vucenik I and Shamsuddin AM: Protection against cancer by dietary IP6 and inositol. Nutr Cancer 55: 109-125, 2006.
35. Wattenberg LW and Estensen RD: Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 56: 5132-5135, 1996.
36. Witschi H, Espiritu I and Uyeminami D: Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis 20: 1375-1378, 1999.
37. Kassie F, Kalscheuer S, Matise I, Ma L, Melkamu T, Upadhyaya P and Hecht SS: Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice. Carcinogenesis 31: 239-245, 2010.
38. Kassie F, Matise I, Negia M, Lahti D, Pan Y, Scherber R, Upadhyaya P and Hecht SS: Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice. Cancer Prev Res (Phila) 1: 285-297, 2008.
39. Memmott RM and Dennis PA: The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis. Clin Cancer Res 16: 4-10, 2010.
40. Kawase T, Ohki R, Shibata T, Tsutsumi S, Kamimura N, Inazawa J, Ohta T, Ichikawa H, Aburatani H, Tashiro F, et al: PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt. Cell 136: 535-550, 2009.
41. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA: Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7, 1994.